Following one of the largest studies ever conducted in Parkinson’s disease (PD), researchers report that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.
Following one of the largest studies ever conducted in Parkinson’s disease (PD), researchers report that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.